Copyright Reports & Markets. All rights reserved.

Global Gaucher Disease (GD) Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gaucher Disease (GD) Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Enzyme Replacement Therapy
      • 1.4.3 Substrate Reduction Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Gaucher Disease (GD) Drugs Market Share by Application (2019-2025)
      • 1.5.2 Non-neuronopathic Gaucher Disease
      • 1.5.3 Neuronopathic Gaucher Disease
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gaucher Disease (GD) Drugs Market Size
    • 2.2 Gaucher Disease (GD) Drugs Growth Trends by Regions
      • 2.2.1 Gaucher Disease (GD) Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Gaucher Disease (GD) Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Gaucher Disease (GD) Drugs Market Size by by Players
      • 3.1.1 Global Gaucher Disease (GD) Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Gaucher Disease (GD) Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Gaucher Disease (GD) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gaucher Disease (GD) Drugs Key Players Head office and Area Served
    • 3.3 Key Players Gaucher Disease (GD) Drugs Product/Solution/Service
    • 3.4 Date of Enter into Gaucher Disease (GD) Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gaucher Disease (GD) Drugs Market Size by Type (2014-2019)
    • 4.2 Global Gaucher Disease (GD) Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 5.2 Gaucher Disease (GD) Drugs Key Players in North America
    • 5.3 North America Gaucher Disease (GD) Drugs Market Size by Type
    • 5.4 North America Gaucher Disease (GD) Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 6.2 Gaucher Disease (GD) Drugs Key Players in Europe
    • 6.3 Europe Gaucher Disease (GD) Drugs Market Size by Type
    • 6.4 Europe Gaucher Disease (GD) Drugs Market Size by Application

    7 China

    • 7.1 China Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 7.2 Gaucher Disease (GD) Drugs Key Players in China
    • 7.3 China Gaucher Disease (GD) Drugs Market Size by Type
    • 7.4 China Gaucher Disease (GD) Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 8.2 Gaucher Disease (GD) Drugs Key Players in Japan
    • 8.3 Japan Gaucher Disease (GD) Drugs Market Size by Type
    • 8.4 Japan Gaucher Disease (GD) Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 9.2 Gaucher Disease (GD) Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Gaucher Disease (GD) Drugs Market Size by Type
    • 9.4 Southeast Asia Gaucher Disease (GD) Drugs Market Size by Application

    10 India

    • 10.1 India Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 10.2 Gaucher Disease (GD) Drugs Key Players in India
    • 10.3 India Gaucher Disease (GD) Drugs Market Size by Type
    • 10.4 India Gaucher Disease (GD) Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gaucher Disease (GD) Drugs Market Size (2014-2019)
    • 11.2 Gaucher Disease (GD) Drugs Key Players in Central & South America
    • 11.3 Central & South America Gaucher Disease (GD) Drugs Market Size by Type
    • 11.4 Central & South America Gaucher Disease (GD) Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gaucher Disease (GD) Drugs Introduction
      • 12.1.4 Sanofi Revenue in Gaucher Disease (GD) Drugs Business (2014-2019))
      • 12.1.5 Sanofi Recent Development
    • 12.2 Shire
      • 12.2.1 Shire Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gaucher Disease (GD) Drugs Introduction
      • 12.2.4 Shire Revenue in Gaucher Disease (GD) Drugs Business (2014-2019)
      • 12.2.5 Shire Recent Development
    • 12.3 Actelion Pharma
      • 12.3.1 Actelion Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gaucher Disease (GD) Drugs Introduction
      • 12.3.4 Actelion Pharma Revenue in Gaucher Disease (GD) Drugs Business (2014-2019)
      • 12.3.5 Actelion Pharma Recent Development
    • 12.4 Pfizer (Protalix)
      • 12.4.1 Pfizer (Protalix) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gaucher Disease (GD) Drugs Introduction
      • 12.4.4 Pfizer (Protalix) Revenue in Gaucher Disease (GD) Drugs Business (2014-2019)
      • 12.4.5 Pfizer (Protalix) Recent Development
    • 12.5 ISU ABXIS
      • 12.5.1 ISU ABXIS Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gaucher Disease (GD) Drugs Introduction
      • 12.5.4 ISU ABXIS Revenue in Gaucher Disease (GD) Drugs Business (2014-2019)
      • 12.5.5 ISU ABXIS Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Gaucher Disease (GD) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gaucher Disease (GD) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Sanofi
      Shire
      Actelion Pharma
      Pfizer (Protalix)
      ISU ABXIS
      ...

      Market segment by Type, the product can be split into
      Enzyme Replacement Therapy
      Substrate Reduction Therapy

      Market segment by Application, split into
      Non-neuronopathic Gaucher Disease
      Neuronopathic Gaucher Disease

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gaucher Disease (GD) Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Gaucher Disease (GD) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gaucher Disease (GD) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now